Section on Affective Neuroscience and Pain, National Center for Complementary and Integrative Health, NIH, Bethesda, MD, United States.
Section on Affective Neuroscience and Pain, National Center for Complementary and Integrative Health, NIH, Bethesda, MD, United States; National Institute on Drug Abuse, NIH, Bethesda, MD, United States.
Int Rev Neurobiol. 2018;138:161-179. doi: 10.1016/bs.irn.2018.01.006. Epub 2018 Feb 28.
Placebo effects are beneficial clinical outcomes that emerge as a result of nonspecific contextual factors, transmitted primarily by the treating physician and the social, physical, and behavioral cues he or she displays. The patient-provider therapeutic alliance is critical for determining placebo effects and health outcomes. In this chapter, we review the recent literature, suggesting that provider social characteristics modulate placebo and clinical outcomes. We highlight the importance of studying not only the provider but also the patient's perception of the provider, which is subject to the influence of the patient's psychosocial orientation, such as their psychosocial motivations and perceptions of their interpersonal relationships broadly. We argue that psychosocial orientation can exaggerate the influence of the patient-provider relationship on placebo effects and can directly affect the likelihood of placebo effects emerging by modulating the underlying biological systems that support them. Here, we examine patient loneliness, or perceived social isolation, as a case example for understanding how patients' psychosocial orientation may affect placebo effects across diseases. We propose psychosocial mechanisms by which loneliness might modulate placebo effects across medical outcomes, and focus in particular on how loneliness might specifically alter behaviorally conditioned immune responses and placebo analgesia. Future studies should directly measure social factors to formally test the effects of social isolation on placebo effects and better elucidate the role of psychosocial and interpersonal factors in placebo effects and clinical outcomes.
安慰剂效应是一种有益的临床结果,它是由于非特异性的环境因素而产生的,主要通过治疗医生以及他或她所表现出的社会、身体和行为暗示来传递。医患治疗联盟对于确定安慰剂效应和健康结果至关重要。在本章中,我们回顾了最新的文献,表明提供者的社会特征调节着安慰剂和临床结果。我们强调不仅要研究提供者,还要研究患者对提供者的感知,这受到患者的社会心理取向的影响,例如他们的社会心理动机和对人际关系的普遍看法。我们认为,社会心理取向会夸大医患关系对安慰剂效应的影响,并通过调节支持安慰剂效应的潜在生物学系统,直接影响安慰剂效应出现的可能性。在这里,我们以患者孤独感或感知的社会隔离为例,来理解患者的社会心理取向如何影响各种疾病中的安慰剂效应。我们提出了孤独感可能调节各种医学结果中的安慰剂效应的心理社会机制,并特别关注孤独感如何具体改变行为条件免疫反应和安慰剂镇痛。未来的研究应该直接测量社会因素,以正式检验社会隔离对安慰剂效应的影响,并更好地阐明社会心理和人际因素在安慰剂效应和临床结果中的作用。